Tanzisertib Terminated Phase 2 Trials for Discoid Lupus Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01466725A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus